サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：顧みられない熱帯病診断の世界市場（2022年～2028年）：疾患別、診断法別、サービスタイプ別、最終用途別、地域別の市場規模調査と予測
市場調査レポート
商品コード
1084087

顧みられない熱帯病診断の世界市場（2022年～2028年）：疾患別、診断法別、サービスタイプ別、最終用途別、地域別の市場規模調査と予測

Global Neglected Tropical Diseases Diagnosis Market Size study, by Disease, By Diagnostic, By Service Type, By End-use and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
顧みられない熱帯病診断の世界市場（2022年～2028年）：疾患別、診断法別、サービスタイプ別、最終用途別、地域別の市場規模調査と予測
出版日: 2022年05月27日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の顧みられない熱帯病診断の市場規模は、2021年に約6,900万米ドルとなり、2022年～2028年の予測期間中に4.5%を超える健全な成長率で拡大すると予想されています。市場を牽引する主な要因には、在宅医療におけるポイントオブケア検査サービスの導入が進んでいること、リンパ系フィラリア症の治療のための迅速診断検査に対する需要の高まり、よりシンプルな疾患診断プラットフォームの開発に対するヘルスケア企業の継続的な取り組みの増加などがあります。しかし、低開発地域では伝染病の予防や治療に対する意識が低く、有利な償還政策もないため、市場の成長が妨げられています。

当レポートでは世界の顧みられない熱帯病診断市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の顧みられない熱帯病診断市場：定義と範囲

第3章 世界の顧みられない熱帯病診断：市場力学

  • 顧みられない熱帯病診断市場：影響分析（2020年～2028年）

第4章 世界の顧みられない熱帯病診断市場：業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要な投資機会
  • 主要な成功戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19以前およびCOVID-19後の市場シナリオ

第6章 世界の顧みられない熱帯病診断市場：疾患別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • デング熱
    • チクングニア熱
    • 狂犬病
    • ハンセン病
    • ブルーリ潰瘍
    • フランベジア
    • リンパ系フィラリア症
    • 条虫症/嚢虫症
    • 食中毒
    • エキノコックス症
    • シャーガス病（アメリカトリパノソーマ症）
    • メジナ虫症
    • アフリカトリパノソーマ症
    • 土壌伝播蠕虫感染症
    • オンコセルカ症
    • 住血吸虫症
    • 疥癬およびその他の外部寄生虫
    • 蛇咬傷毒
    • リーシュマニア症

第7章 世界の顧みられない熱帯病診断市場：最終用途別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • 臨床検査所
    • 病院/診療所
    • 在宅医療

第8章 世界の顧みられない熱帯病診断市場：診断法別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • 従来型
    • 分子/現代型

第9章 世界の顧みられない熱帯病診断市場：サービスタイプ別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • 一元化サービス
    • POCサービス

第10章 世界の顧みられない熱帯病診断市場：地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第11章 競合情勢

  • 主な市場戦略
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd
    • Abbott
    • Thermo Fisher Scientific Inc.
    • ZeptoMetrix
    • InBios International, Inc.
    • Genome Diagnostics Pvt. Ltd.
    • Omega Diagnostics Group PLC
    • Coris BioConcept
    • DiaSys Diagnostic Systems GmbH
    • Oscar Medicare Pvt Ltd.

第12章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Neglected Tropical Diseases Diagnosis Market, report scope
  • TABLE 2. Global Neglected Tropical Diseases Diagnosis Market estimates & forecasts by Region 2018-2028 (USD Million)
  • TABLE 3. Global Neglected Tropical Diseases Diagnosis Market estimates & forecasts by Disease 2018-2028 (USD Million)
  • TABLE 4. Global Neglected Tropical Diseases Diagnosis Market estimates & forecasts by End-use 2018-2028 (USD Million)
  • TABLE 5. Global Neglected Tropical Diseases Diagnosis Market estimates & forecasts by Diagnostic 2018-2028 (USD Million)
  • TABLE 6. Global Neglected Tropical Diseases Diagnosis Market estimates & forecasts by Service Type 2018-2028 (USD Million)
  • TABLE 7. Global Neglected Tropical Diseases Diagnosis Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Neglected Tropical Diseases Diagnosis Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Neglected Tropical Diseases Diagnosis Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Neglected Tropical Diseases Diagnosis Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Neglected Tropical Diseases Diagnosis Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Neglected Tropical Diseases Diagnosis Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Neglected Tropical Diseases Diagnosis Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Neglected Tropical Diseases Diagnosis Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. Global Neglected Tropical Diseases Diagnosis Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. Global Neglected Tropical Diseases Diagnosis Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 17. U.S. Neglected Tropical Diseases Diagnosis Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 18. U.S. Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 19. U.S. Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 20. Canada Neglected Tropical Diseases Diagnosis Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 21. Canada Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 22. Canada Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 23. UK Neglected Tropical Diseases Diagnosis Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 24. UK Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 25. UK Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 26. Germany Neglected Tropical Diseases Diagnosis Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 27. Germany Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 28. Germany Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 29. RoE Neglected Tropical Diseases Diagnosis Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 30. RoE Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 31. RoE Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 32. China Neglected Tropical Diseases Diagnosis Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 33. China Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 34. China Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 35. India Neglected Tropical Diseases Diagnosis Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 36. India Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 37. India Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 38. Japan Neglected Tropical Diseases Diagnosis Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 39. Japan Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 40. Japan Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Neglected Tropical Diseases Diagnosis Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 42. RoAPAC Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 43. RoAPAC Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 44. Brazil Neglected Tropical Diseases Diagnosis Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 45. Brazil Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 46. Brazil Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 47. Mexico Neglected Tropical Diseases Diagnosis Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 48. Mexico Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 49. Mexico Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 50. RoLA Neglected Tropical Diseases Diagnosis Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 51. RoLA Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 52. RoLA Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 53. Row Neglected Tropical Diseases Diagnosis Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 54. Row Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 55. Row Neglected Tropical Diseases Diagnosis Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 56. List of secondary sources, used in the study of global Neglected Tropical Diseases Diagnosis Market
  • TABLE 57. List of primary sources, used in the study of global Neglected Tropical Diseases Diagnosis Market
  • TABLE 58. Years considered for the study
  • TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Neglected Tropical Diseases Diagnosis Market, research methodology
  • FIG 2. Global Neglected Tropical Diseases Diagnosis Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Neglected Tropical Diseases Diagnosis Market, key trends 2021
  • FIG 5. Global Neglected Tropical Diseases Diagnosis Market, growth prospects 2022-2028
  • FIG 6. Global Neglected Tropical Diseases Diagnosis Market, porters 5 force model
  • FIG 7. Global Neglected Tropical Diseases Diagnosis Market, pest analysis
  • FIG 8. Global Neglected Tropical Diseases Diagnosis Market, value chain analysis
  • FIG 9. Global Neglected Tropical Diseases Diagnosis Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Neglected Tropical Diseases Diagnosis Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Neglected Tropical Diseases Diagnosis Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Neglected Tropical Diseases Diagnosis Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Neglected Tropical Diseases Diagnosis Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Neglected Tropical Diseases Diagnosis Market, regional snapshot 2018 & 2028
  • FIG 15. North America Neglected Tropical Diseases Diagnosis Market2018 & 2028 (USD Million)
  • FIG 16. Europe Neglected Tropical Diseases Diagnosis Market 2018 & 2028 (USD Million)
  • FIG 17. Asia Pacific Neglected Tropical Diseases Diagnosis Market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Neglected Tropical Diseases Diagnosis Market 2018 & 2028 (USD Million)
  • FIG 19. Global Neglected Tropical Diseases Diagnosis Market, company market share analysis (2021)
目次

Global Neglected Tropical Diseases Diagnosis Market is valued at approximately USD 6.9 Million in 2021 and is anticipated to grow with a healthy growth rate of more than 4.5% over the forecast period 2022-2028. Neglected tropical diseases (NTDs) are infections caused by viruses, bacteria, or parasites that are common in low-income populations and affect poor people all over the world. These untreated tropical diseases are also associated with high levels of morbidity due to the pathogens' chronic existence. The increasing adoption of point-of-care testing services in home healthcare, rising demand for rapid diagnostic tests for the treatment of lymphatic filariasis, and increasing continuous efforts by healthcare companies to develop less complicated disease diagnostic platforms are the factors expected to drive the growth of the Neglected Tropical Diseases Diagnosis Market during the forecast period. According to WHO estimates, more than 1.7 billion people, or about one-fifth of the world's population, needed treatment for at least one NTD each year, mostly in low-income and developing countries. NTDs affected approximately 40% of the African continent. These diseases are more common among the poor who live in tropical climates and difficult-to-reach areas. However, low level of awareness of contagious disease prevention and treatment in underdeveloped areas, as well as a lack of favourable reimbursement policies, are limiting the market growth. Moreover, various WHO initiatives, such as the road map 2030 for the elimination of NTDs, are expected to drive market growth over the forecast period. Government agencies like the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) work with counties to improve public health services for NTDs. Furthermore, the WHO released its NTDs roadmap for the years 2021 to 2030 in January 2021. Its goal is to improve global prevention and control of neglected tropical diseases. During the forecast period, government initiatives are expected to drive market growth.

The key regions considered for the global Neglected Tropical Diseases Diagnosis market study include: Asia Pacific, North America, Europe, Latin America, and Rest of the World. Geographically, the North American Neglected Tropical Diseases Diagnosis Market had the highest revenue share and it is expected to continue dominating between 2022 and 2028, owing to the rising demand for rapid diagnostic tests for lymphatic filariasis treatment. Whereas, because of increased IVD product penetration and the high disease burden of NTDs in developing countries in the region, Latin America is expected to have the fastest CAGR over the forecast period. Furthermore, increased government spending, the presence of skilled healthcare professionals, and multinational diagnostic companies' increased focus on the development of advanced and novel IVD products are among the factors likely to drive market growth in Latin America.

ByMajor market players included in this report are:

  • F. Hoffmann-La Roche Ltd
  • Abbott
  • Thermo Fisher Scientific Inc.
  • ZeptoMetrix
  • InBios International, Inc.
  • Genome Diagnostics Pvt. Ltd.
  • Omega Diagnostics Group PLC
  • Coris BioConcept
  • DiaSys Diagnostic Systems GmbH
  • Oscar Medicare Pvt Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease:

  • Dengue
  • Chikungunya
  • Rabies
  • Leprosy
  • Buruli Ulcer
  • Yaws
  • Lymphatic Filariasis
  • Taeniasis/Cysticercosis
  • Foodborne Trematodiases
  • Echinococcosis
  • Chagas Disease (American Trypanosomiasis)
  • Dracunculiasis
  • African Trypanosomiasis
  • Soil-transmitted Helminth Infections
  • Onchocerciasis
  • Schistosomiasis
  • Scabies and Other Ectoparasites
  • Snakebite Envenoming
  • Leishmaniasis

By Diagnostic:

  • Conventional Method
  • Molecular/Modern Method

By Service Type:

  • Centralized Service
  • POC Service

By End-Use:

  • Clinical Labs
  • Hospitals /Clinics
  • Home Healthcare

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

ByFurthermore, years considered for the study are as follows:

  • Historical year - 2018, 2019, 2020
  • Base year - 2021
  • Forecast period - 2022 to 2028

ByTarget Audience of the Global Neglected Tropical Diseases Diagnosis Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Neglected Tropical Diseases Diagnosis Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Neglected Tropical Diseases Diagnosis Market, by Disease, 2020-2028 (USD Million)
    • 1.2.3. Neglected Tropical Diseases Diagnosis Market, by End-use, 2020-2028 (USD Million)
    • 1.2.4. Neglected Tropical Diseases Diagnosis Market, by Diagnostic, 2020-2028 (USD Million)
    • 1.2.5. Neglected Tropical Diseases Diagnosis Market, by Service Type, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Neglected Tropical Diseases Diagnosis Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Neglected Tropical Diseases Diagnosis Market Dynamics

  • 3.1. Neglected Tropical Diseases Diagnosis Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rise in the adoption of point-of-care testing
      • 3.1.1.2. Rising concern regarding Neglected Tropical Diseases (NTD)
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost for diagnosis
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing demand for rapid diagnostic tests for the treatment of lymphatic filariasis

Chapter 4. Global Neglected Tropical Diseases Diagnosis Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Neglected Tropical Diseases Diagnosis Market, by Disease

  • 6.1. Market Snapshot
  • 6.2. Global Neglected Tropical Diseases Diagnosis Market by Disease, Performance - Potential Analysis
  • 6.3. Global Neglected Tropical Diseases Diagnosis Market Estimates & Forecasts by Disease, 2018-2028 (USD Million)
  • 6.4. Neglected Tropical Diseases Diagnosis Market, Sub Segment Analysis
    • 6.4.1. Dengue
    • 6.4.2. Chikungunya
    • 6.4.3. Rabies
    • 6.4.4. Leprosy
    • 6.4.5. Buruli Ulcer
    • 6.4.6. Yaws
    • 6.4.7. Lymphatic Filariasis
    • 6.4.8. Taeniasis/Cysticercosis
    • 6.4.9. Foodborne Trematodiases
    • 6.4.10. Echinococcosis
    • 6.4.11. Chagas Disease (American Trypanosomiasis)
    • 6.4.12. Dracunculiasis
    • 6.4.13. African Trypanosomiasis
    • 6.4.14. Soil-transmitted Helminth Infections
    • 6.4.15. Onchocerciasis
    • 6.4.16. Schistosomiasis
    • 6.4.17. Scabies and Other Ectoparasites
    • 6.4.18. Snakebite Envenoming
    • 6.4.19. Leishmaniasis

Chapter 7. Global Neglected Tropical Diseases Diagnosis Market, by End-use

  • 7.1. Market Snapshot
  • 7.2. Global Neglected Tropical Diseases Diagnosis Market by End-use, Performance - Potential Analysis
  • 7.3. Global Neglected Tropical Diseases Diagnosis Market Estimates & Forecasts by End-use, 2018-2028 (USD Million)
  • 7.4. Neglected Tropical Diseases Diagnosis Market, Sub Segment Analysis
    • 7.4.1. Clinical Labs
    • 7.4.2. Hospitals /Clinics
    • 7.4.3. Home Healthcare

Chapter 8. Global Neglected Tropical Diseases Diagnosis Market, by Diagnostic

  • 8.1. Market Snapshot
  • 8.2. Global Neglected Tropical Diseases Diagnosis Market by Diagnostic, Performance - Potential Analysis
  • 8.3. Global Neglected Tropical Diseases Diagnosis Market Estimates & Forecasts by Diagnostic, 2018-2028 (USD Million)
  • 8.4. Neglected Tropical Diseases Diagnosis Market, Sub Segment Analysis
    • 8.4.1. Conventional Method
    • 8.4.2. Molecular/Modern Method

Chapter 9. Global Neglected Tropical Diseases Diagnosis Market, by Service Type

  • 9.1. Market Snapshot
  • 9.2. Global Neglected Tropical Diseases Diagnosis Market by Service Type, Performance - Potential Analysis
  • 9.3. Global Neglected Tropical Diseases Diagnosis Market Estimates & Forecasts by Service Type, 2018-2028 (USD Million)
  • 9.4. Neglected Tropical Diseases Diagnosis Market, Sub Segment Analysis
    • 9.4.1. Centralized Service
    • 9.4.2. POC Service

Chapter 10. Global Neglected Tropical Diseases Diagnosis Market, Regional Analysis

  • 10.1. Neglected Tropical Diseases Diagnosis Market, Regional Market Snapshot
  • 10.2. North America Neglected Tropical Diseases Diagnosis Market
    • 10.2.1. U.S. Neglected Tropical Diseases Diagnosis Market
      • 10.2.1.1. Disease breakdown estimates & forecasts, 2018-2028
      • 10.2.1.2. End-use breakdown estimates & forecasts, 2018-2028
      • 10.2.1.3. Diagnostic breakdown estimates & forecasts, 2018-2028
      • 10.2.1.4. Service Type breakdown estimates & forecasts, 2018-2028
    • 10.2.2. Canada Neglected Tropical Diseases Diagnosis Market
  • 10.3. Europe Neglected Tropical Diseases Diagnosis Market Snapshot
    • 10.3.1. U.K. Neglected Tropical Diseases Diagnosis Market
    • 10.3.2. Germany Neglected Tropical Diseases Diagnosis Market
    • 10.3.3. France Neglected Tropical Diseases Diagnosis Market
    • 10.3.4. Spain Neglected Tropical Diseases Diagnosis Market
    • 10.3.5. Italy Neglected Tropical Diseases Diagnosis Market
    • 10.3.6. Rest of Europe Neglected Tropical Diseases Diagnosis Market
  • 10.4. Asia-Pacific Neglected Tropical Diseases Diagnosis Market Snapshot
    • 10.4.1. China Neglected Tropical Diseases Diagnosis Market
    • 10.4.2. India Neglected Tropical Diseases Diagnosis Market
    • 10.4.3. Japan Neglected Tropical Diseases Diagnosis Market
    • 10.4.4. Australia Neglected Tropical Diseases Diagnosis Market
    • 10.4.5. South Korea Neglected Tropical Diseases Diagnosis Market
    • 10.4.6. Rest of Asia Pacific Neglected Tropical Diseases Diagnosis Market
  • 10.5. Latin America Neglected Tropical Diseases Diagnosis Market Snapshot
    • 10.5.1. Brazil Neglected Tropical Diseases Diagnosis Market
    • 10.5.2. Mexico Neglected Tropical Diseases Diagnosis Market
  • 10.6. Rest of The World Neglected Tropical Diseases Diagnosis Market

Chapter 11. Competitive Intelligence

  • 11.1. Top Market Strategies
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd
      • 11.2.1.1. Key Information
      • 11.2.1.2. Overview
      • 11.2.1.3. Financial (Subject to Data Availability)
      • 11.2.1.4. End-use Summary
      • 11.2.1.5. Recent Developments
    • 11.2.2. Abbott
    • 11.2.3. Thermo Fisher Scientific Inc.
    • 11.2.4. ZeptoMetrix
    • 11.2.5. InBios International, Inc.
    • 11.2.6. Genome Diagnostics Pvt. Ltd.
    • 11.2.7. Omega Diagnostics Group PLC
    • 11.2.8. Coris BioConcept
    • 11.2.9. DiaSys Diagnostic Systems GmbH
    • 11.2.10. Oscar Medicare Pvt Ltd.

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption